Literature DB >> 18338129

Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging.

M D'Onofrio1, F Vecchiato, V Cantisani, E Barbi, M Passamonti, P Ricci, R Malagò, N Faccioli, G Zamboni, R Pozzi Mucelli.   

Abstract

PURPOSE: This study was done to compare the perfusion patterns of intrahepatic peripheral cholangiocarcinoma (IPCC) on contrast-enhanced ultrasound (CEUS) and dynamic computed tomography (CT).
MATERIALS AND METHODS: We retrospectively reviewed 23 histologically proven cases of IPCC. All lesions were studied by CEUS with sulfur hexafluoride-filled microbubbles coated with a phospholipid capsule, and by dynamic CT. Contrast-enhancement patterns were evaluated in the arterial phase (CEUS 10-20 s after the injection; CT 25-30 s after the injection) and in the delayed phase (CEUS 120 s after the injection; CT>2-3 min after the injection).
RESULTS: Lesions were single in 18/23 cases (78%), single with nearby satellite lesions in 1/23 (4%) cases and multifocal with distant secondary lesions in 4/23 (17%) cases. Lesion diameter was 2-5 cm in 7/23 cases (30%), 5-7 cm in 13/23 cases (57%) and >7 cm in 3/23 (13%) cases. On CEUS, lesions were hypervascular in 16/23 cases (70%). On delayed-phase CEUS, 22/23 lesions (96%) were markedly hypoechoic. CT showed that the lesions were hypovascular in the arterial phase in 15/23 cases (66%) and hypervascular in 7/23 (30%) cases; one lesion (1/23; 4%) was isovascular. On delayed-phase CT, lesions were hyperdense in 17/23 cases (74%), hypodense in 5/23 (22%) cases and isodense in 1/23 (43%) cases.
CONCLUSIONS: Enhancement discrepancy between delayed-phase CEUS (hypoechogenicity) and CT (hyperdensity) is common semiological findings in the study of IPCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338129     DOI: 10.1007/s11547-008-0225-1

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  33 in total

Review 1.  The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions.

Authors:  E Leen
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

2.  Intrahepatic peripheral cholangiocarcinoma: CT evaluation.

Authors:  C Valls; A Gumà; I Puig; A Sanchez; E Andía; T Serrano; J Figueras
Journal:  Abdom Imaging       Date:  2000 Sep-Oct

Review 3.  Imaging of intrahepatic and hilar cholangiocarcinoma.

Authors:  B I Choi; J M Lee; J K Han
Journal:  Abdom Imaging       Date:  2004-06-08

4.  Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.

Authors:  Emilio Quaia; Fabrizio Calliada; Michele Bertolotto; Sandro Rossi; Lorena Garioni; Laura Rosa; Roberto Pozzi-Mucelli
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

5.  MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.

Authors:  Y Maetani; K Itoh; C Watanabe; T Shibata; F Ametani; H Yamabe; J Konishi
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

6.  Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings.

Authors:  T K Kim; B I Choi; J K Han; H J Jang; S G Cho; M C Han
Journal:  Radiology       Date:  1997-08       Impact factor: 11.105

7.  Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI.

Authors:  Y Zhang; M Uchida; T Abe; H Nishimura; N Hayabuchi; Y Nakashima
Journal:  J Comput Assist Tomogr       Date:  1999 Sep-Oct       Impact factor: 1.826

8.  Cholangiocarcinoma: delayed CT contrast enhancement patterns.

Authors:  J M Lacomis; R L Baron; J H Oliver; M A Nalesnik; M P Federle
Journal:  Radiology       Date:  1997-04       Impact factor: 11.105

9.  Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation.

Authors:  P R Ros; J L Buck; Z D Goodman; A M Ros; W W Olmsted
Journal:  Radiology       Date:  1988-06       Impact factor: 11.105

10.  Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma.

Authors:  P Soyer; D A Bluemke; R Reichle; P S Calhoun; D F Bliss; A Scherrer; E K Fishman
Journal:  AJR Am J Roentgenol       Date:  1995-12       Impact factor: 3.959

View more
  13 in total

1.  Characterisation of focal liver lesions undetermined at grey-scale US: contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent.

Authors:  T V Bartolotta; A Taibbi; M Midiri; L La Grutta; M De Maria; R Lagalla
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

2.  Comparing enhancement and washout patterns of hepatic lesions between sonazoid-enhanced ultrasound and contrast-enhanced computed tomography.

Authors:  Sneha Patel; Akiko Saito; Yuki Yoneda; Toshio Hayano; Keiko Shiratori
Journal:  J Med Ultrason (2001)       Date:  2010-07-27       Impact factor: 1.314

3.  Isolated fallopian tube metastasis from colorectal cancer: ultrasonographic features.

Authors:  V Balaya; U Metzger; C Denet; M Herry; F Lecuru
Journal:  J Ultrasound       Date:  2017-08-21

Review 4.  Evaluation of gallbladder and biliary duct disease using microbubble contrast-enhanced ultrasound.

Authors:  L M Meacock; M E Sellars; P S Sidhu
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

5.  Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.

Authors:  Elisabetta Sagrini; Massimo Iavarone; Federico Stefanini; Francesco Tovoli; Sara Vavassori; Marco Maggioni; Matteo Renzulli; Veronica Salvatore; Horia Stefanescu; Massimo Colombo; Luigi Bolondi; Fabio Piscaglia
Journal:  United European Gastroenterol J       Date:  2018-11-22       Impact factor: 4.623

6.  3D-Arterial analysis software and CEUS in the assessment of severity and vulnerability of carotid atherosclerotic plaque: a comparison with CTA and histopathology.

Authors:  Daniele Fresilli; Nicola Di Leo; Ombretta Martinelli; Luca Di Marzo; Patrizia Pacini; Vincenzo Dolcetti; Giovanni Del Gaudio; Fabrizio Canni; Ludovica Isabella Ricci; Corrado De Vito; Corrado Caiazzo; Raffaella Carletti; Cira Di Gioia; Iacopo Carbone; Steven B Feinstein; Carlo Catalano; Vito Cantisani
Journal:  Radiol Med       Date:  2022-09-17       Impact factor: 6.313

7.  Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Guang-Jian Liu; Wei Wang; Ming-De Lu; Xiao-Yan Xie; Hui-Xiong Xu; Zuo-Feng Xu; Li-Da Chen; Zhu Wang; Jin-Yu Liang; Yang Huang; Wei Li; Jin-Ya Liu
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

8.  Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension.

Authors:  Siciliani Luisa; Giovanna Vitale; Anna Rita Sorbo; Pompili Maurizio; Rapaccini Gian Lodovico
Journal:  J Ultrasound       Date:  2016-12-01

9.  What is the role of contrast-enhanced ultrasound in the evaluation of the endoleak of aortic endoprostheses? A comparison between CEUS and CT on a widespread scale.

Authors:  E David; V Cantisani; H Grazhdani; L Di Marzo; L Venturini; F Fanelli; M Di Segni; N Di Leo; L Brunese; F Calliada; M Ciccariello; A Bottari; G Ascenti; F D'Ambrosio
Journal:  J Ultrasound       Date:  2016-11-23

Review 10.  Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.

Authors:  Jae Young Jang; Moon Young Kim; Soung Won Jeong; Tae Yeob Kim; Seung Up Kim; Sae Hwan Lee; Ki Tae Suk; Soo Young Park; Hyun Young Woo; Sang Gyune Kim; Jeong Heo; Soon Koo Baik; Hong Soo Kim; Won Young Tak
Journal:  Clin Mol Hepatol       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.